Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein a vaccine

Journal of Infectious Diseases

Volumn 174, Issue 4, 1996, Pages 739-746

  Padilla, Marcia L ^b   Callister, Steven M ^a   Schell, Ronald F ^b   Bryant, Gary L ^b   Jobe, Dean A ^b   Lovrich, Steven D ^b   DuChateau, Brian K ^b   Jensen, Jani R ^b  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; PROTEIN A; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERICIDAL ACTIVITY; BORRELIA BURGDORFERI; CLINICAL TRIAL; FEMALE; HAMSTER; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; VACCINATION;

EID: 0029792824     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.4.739     Document Type: Article

References (11)

1. Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977;20:7-17.
2. Johnson RC, Kodner C, Russell M. Active immunization of hamsters against experimental infection with Borrelia burgdorferi. Infect Immun 1986;54:897-8.
3. Johnson RC, Kodner C, Russell M. Passive immunization of hamsters against experimental infection with the Lyme disease spirochete. Infect Immun 1986;53:713-4.
4. Schmitz JL, Schell RF, Heyka AG, England DM. Passive immunization prevents induction of Lyme arthritis in LSH hamsters. Infect Immun 1990;58:144-8.
5. Schmitz JL, Schell RF, Lovrich SD, Callister SM, Coe JE. Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters. Infect Immun 1991;59:1916-21.
6. Callister SM, Schell RF, Case KL, Lovrich SD, Day SP. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J Infect Dis 1993;167:158-64.
7. Fikrig E, Bockenstedt LK, Barthold SW, et al. Sera from patients with chronic Lyme disease protects mice from Lyme borreliosis. J Infect Dis 1994;169:568-74.
8. Lovrich SD, Callister SM, DuChateau BK, et al. Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection. Infect Immun 1995;63:2113-9.
9. Lovrich SD, Callister SM, Lim LCL, DuChateau BK, Schell RF. Seroprotective groups of Lyme borreliosis spirochetes from North America and Europe. J Infect Dis 1994;170:115-21.
10. Probert WS, LeFebvre RB. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen. Infect Immun 1994;62:1920-6.
11. Simon MM, Schaible DE, Kramer MD, et al. Recombinant outer surface protein A from Borrelia burgdorferi induces antibodies protective against spirochaetal infection in mice. J Infect Dis 1991;164:123-32.